{
    "content": "<?xml version=\"1.0\" encoding=\"UTF-8\"?> <feed xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns=\"http://www.w3.org/2005/Atom\"> <title>Department of Medical Genetics</title> <link href=\"http://www.repository.cam.ac.uk:80/handle/1810/221771\" rel=\"alternate\"/> <subtitle/> <id>http://www.repository.cam.ac.uk:80/handle/1810/221771</id> <updated>2015-03-12T02:53:56Z</updated> <dc:date>2015-03-12T02:53:56Z</dc:date> <entry> <title>PI(5)P Regulates Autophagosome Biogenesis</title> <link href=\"http://www.repository.cam.ac.uk:80/handle/1810/246804\" rel=\"alternate\"/> <author> <name>Vicinanza, Mariella</name> </author> <author> <name>Korolchuk, Viktor I.</name> </author> <author> <name>Ashkenazi, Avraham</name> </author> <author> <name>Puri, Claudia</name> </author> <author> <name>Menzies, Fiona M.</name> </author> <author> <name>Clarke, Jonathan H.</name> </author> <author> <name>Rubinsztein, David C.</name> </author> <id>http://www.repository.cam.ac.uk:80/handle/1810/246804</id> <updated>2015-02-16T17:40:45Z</updated> <published>2015-01-08T00:00:00Z</published> <summary type=\"text\">PI(5)P Regulates Autophagosome Biogenesis Vicinanza, Mariella; Korolchuk, Viktor I.; Ashkenazi, Avraham; Puri, Claudia; Menzies, Fiona M.; Clarke, Jonathan H.; Rubinsztein, David C. Phosphatidylinositol 3-phosphate (PI(3)P), the product of class III PI3K VPS34, recruits specific autophagic effectors, like WIPI2, during the initial steps of autophagosome biogenesis and thereby regulates canonical autophagy. However, mammalian cells can produce autophagosomes through enigmatic noncanonical VPS34-independent pathways. Here we show that PI(5)P can regulate autophagy via PI(3)P effectors and thereby identify a mechanistic explanation for forms of noncanonical autophagy. PI(5)P synthesis by the phosphatidylinositol 5-kinase PIKfyve was required for autophagosome biogenesis, and it increased levels of PI(5)P, stimulated autophagy, and reduced the levels of autophagic substrates. Inactivation of VPS34 impaired recruitment of WIPI2 and DFCP1 to autophagic precursors, reduced ATG5-ATG12 conjugation, and compromised autophagosome formation. However, these phenotypes were rescued by PI(5)P in VPS34-inactivated cells. These findings provide a mechanistic framework for alternative VPS34-independent autophagy-initiating pathways, like glucose starvation, and unravel a cytoplasmic function for PI(5)P, which previously has been linked predominantly to nuclear roles. This article was originally published in Molecular Cell (M Vicinanza, VI Korolchuk, A Ashkenazi, C Puri, FM Menzies, JH Clarke, DC Rubinsztein, Molecular Cell 2015, 57, 219-234) </summary> <dc:date>2015-01-08T00:00:00Z</dc:date> </entry> <entry> <title>Methods to analyze SNARE-dependent vesicular fusion events that regulate autophagosome biogenesis</title> <link href=\"http://www.repository.cam.ac.uk:80/handle/1810/246561\" rel=\"alternate\"/> <author> <name>Moreau, Kevin</name> </author> <author> <name>Puri, Claudia</name> </author> <author> <name>Rubinsztein, David C.</name> </author> <id>http://www.repository.cam.ac.uk:80/handle/1810/246561</id> <updated>2015-01-12T13:58:49Z</updated> <published>2014-11-13T00:00:00Z</published> <summary type=\"text\">Methods to analyze SNARE-dependent vesicular fusion events that regulate autophagosome biogenesis Moreau, Kevin; Puri, Claudia; Rubinsztein, David C. Autophagy is an important catabolic pathway that preserves cellular homeostasis. The formation of autophagosomes is a complex process requiring the reorganization of membranes from different compartments. Here we describe methods to analyze SNARE-dependent vesicular fusion events involving the homotypic and heterotypic fusion of autophagosome precursor structures. These two steps are essential for the maturation of small single-membrane autophagic precursors containing ATG16L1 and mATG9 proteins into double-membrane autophagosomes. The techniques described in this review are mostly based on live cell imaging, microscopy, and biochemistry using an in vitro fusion assay, and should help researchers to study autophagosome biogenesis. This is the proof version. It'll be updated with the final published version when available. It first appeared at http://www.sciencedirect.com/science/article/pii/S104620231400365X#. </summary> <dc:date>2014-11-13T00:00:00Z</dc:date> </entry> <entry> <title>Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells</title> <link href=\"http://www.repository.cam.ac.uk:80/handle/1810/246183\" rel=\"alternate\"/> <author> <name>Bell, Charles J. M.</name> </author> <author> <name>Sun, Yongliang</name> </author> <author> <name>Nowak, Urszula M.</name> </author> <author> <name>Clark, Jan</name> </author> <author> <name>Howlett, Sarah</name> </author> <author> <name>Pekalski, Marcin L.</name> </author> <author> <name>Yang, Xin</name> </author> <author> <name>Ast, Oliver</name> </author> <author> <name>Waldhauer, Inja</name> </author> <author> <name>Freimoser-Grundschober, Anne</name> </author> <author> <name>Moessner, Ekkehard</name> </author> <author> <name>Umana, Pablo</name> </author> <author> <name>Klein, Christian</name> </author> <author> <name>Hosse, Ralf J.</name> </author> <author> <name>Wicker, Linda S.</name> </author> <author> <name>Peterson, Laurence B.</name> </author> <id>http://www.repository.cam.ac.uk:80/handle/1810/246183</id> <updated>2014-10-16T14:40:49Z</updated> <published>2014-01-01T00:00:00Z</published> <summary type=\"text\">Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells Bell, Charles J. M.; Sun, Yongliang; Nowak, Urszula M.; Clark, Jan; Howlett, Sarah; Pekalski, Marcin L.; Yang, Xin; Ast, Oliver; Waldhauer, Inja; Freimoser-Grundschober, Anne; Moessner, Ekkehard; Umana, Pablo; Klein, Christian; Hosse, Ralf J.; Wicker, Linda S.; Peterson, Laurence B. Regulatory T cells (Tregs) expressing FOXP3 are essential for the maintenance of self-tolerance and are deficient in many common autoimmune diseases. Immune tolerance is maintained in part by IL-2 and deficiencies in the IL-2 pathway cause reduced Treg function and an increased risk of autoimmunity. Recent studies expanding Tregs in vivo with low-dose IL-2 achieved major clinical successes highlighting the potential to optimize this pleiotropic cytokine for inflammatory and autoimmune disease indications. Here we compare the clinically approved IL-2 molecule, Proleukin, with two engineered IL-2 molecules with long half-lives owing to their fusion in monovalent and bivalent stoichiometry to a non-FcR\\ufffd\\ufffd binding human IgG1. Using nonhuman primates, we demonstrate that single ultra-low doses of IL-2 fusion proteins induce a prolonged state of in vivo activation that increases Tregs for an extended period of time similar to multiple-dose Proleukin. One of the common pleiotropic effects of high dose IL-2 treatment, eosinophilia, is eliminated at doses of the IL-2 fusion proteins that greatly expand Tregs. The long half-lives of the IL-2 fusion proteins facilitated a detailed characterization of an IL-2 dose response driving Treg expansion that correlates with increasingly sustained, suprathreshold pSTAT5a induction and subsequent sustained increases in the expression of CD25, FOXP3 and Ki-67 with retention of Treg-specific epigenetic signatures at FOXP3 and CTLA4. This is the accepted manuscript. It's currently embargoed pending publication by Elsevier. </summary> <dc:date>2014-01-01T00:00:00Z</dc:date> </entry> <entry> <title>Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity</title> <link href=\"http://www.repository.cam.ac.uk:80/handle/1810/246151\" rel=\"alternate\"/> <author> <name>Menzies, Fiona M.</name> </author> <author> <name>Garcia-Arencibia, Moises</name> </author> <author> <name>Imarisio, Sara</name> </author> <author> <name>O\\ufffd\\ufffd\\ufffdSullivan, Niamh C.</name> </author> <author> <name>Ricketts, Thomas</name> </author> <author> <name>Kent, Brianne A.</name> </author> <author> <name>Rao, Mala V.</name> </author> <author> <name>Lam, Wun</name> </author> <author> <name>Green-Thompson, Zeyn W.</name> </author> <author> <name>Nixon, Ralph A.</name> </author> <author> <name>Saksida, Lisa M.</name> </author> <author> <name>Bussey, Timothy J.</name> </author> <author> <name>O\\ufffd\\ufffd\\ufffdKane, Cahir J.</name> </author> <author> <name>Rubinsztein, David C.</name> </author> <id>http://www.repository.cam.ac.uk:80/handle/1810/246151</id> <updated>2014-10-10T09:40:54Z</updated> <published>2014-09-26T00:00:00Z</published> <summary type=\"text\">Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity Menzies, Fiona M.; Garcia-Arencibia, Moises; Imarisio, Sara; O\\ufffd\\ufffd\\ufffdSullivan, Niamh C.; Ricketts, Thomas; Kent, Brianne A.; Rao, Mala V.; Lam, Wun; Green-Thompson, Zeyn W.; Nixon, Ralph A.; Saksida, Lisa M.; Bussey, Timothy J.; O\\ufffd\\ufffd\\ufffdKane, Cahir J.; Rubinsztein, David C. Over recent years, accumulated evidence suggests that autophagy induction is protective in animal models of a number of neurodegenerative diseases. Intense research in the field has elucidated different pathways through which autophagy can be upregulated and it is important to establish how modulation of these pathways impacts upon disease progression in vivo and therefore which, if any, may have further therapeutic relevance. In addition, it is important to understand how alterations in these target pathways may affect normal physiology when constitutively modulated over a long time period, as would be required for treatment of neurodegenerative diseases. Here we evaluate the potential protective effect of downregulation of calpains. We demonstrate, in Drosophila, that calpain knockdown protects against the aggregation and toxicity of proteins, like mutant huntingtin, in an autophagy-dependent fashion. Furthermore, we demonstrate that, overexpression of the calpain inhibitor, calpastatin, increases autophagosome levels and is protective in a mouse model of Huntington\\ufffd\\ufffd\\ufffds disease, improving motor signs and delaying the onset of tremors. Importantly, long-term inhibition of calpains did not result in any overt deleterious phenotypes in mice. Thus, calpain inhibition, or activation of autophagy pathways downstream of calpains, may be suitable therapeutic targets for diseases like Huntington\\ufffd\\ufffd\\ufffds disease. This is the published version of the manuscript. It is available online from NPG in Cell Death and Differentiaiton here: http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd2014151a.html. </summary> <dc:date>2014-09-26T00:00:00Z</dc:date> </entry> </feed> ", 
    "identity": {
        "subtype": "", 
        "is_error": false, 
        "version": "", 
        "protocol": "", 
        "language": "", 
        "service": "", 
        "has_dataset": false, 
        "has_metadata": false
    }, 
    "digest": "65a7112ad965329993bb46b7f38eaa2c", 
    "source_url": "https://www.repository.cam.ac.uk/feed/atom_1.0/1810/221771"
}